Paclitaxel (T) following doxorubicin/cyclophosphamide(AC) as adjuvant chemotherapy for node positive breast cancer: Results from NSABP B-28

Reviewer: Walter Sall, MD
OncoLink
Ultima Vez Modificado: 31 de mayo del 2003

Translation for this article does not exist